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1 Zusammenfassung 
 
Die Leber des Menschen ist ein Organ mit erstaunlichen Selbstheilungskräften. 
Die Frage nach Faktoren, welche die Gesundheit und das 
Regenerationspotential dieses Organs erhalten ist seit langem Gegenstand 
wissenschaftlichen Interesses in der Hepatologie. 
Anatomisch einzigartig erhält die Leber den Großteil ihrer Blutversorgung aus 
dem Darm. Es reiht sich ein vorgeschaltetes intestinales Kapillarstromgebiet an 
ein nachgeschaltetes hepatisches Kapillarstromgebiet. Mit Hilfe von Enterozyten 
werden Stoffe aus der Umwelt in den Blutkreislauf aufgenommen und gelangen 
über die Pfortader direkt und teils noch unverarbeitet in das hepatische Gewebe. 
 
Diese im menschlichen Körper einzigartige Blutversorgung der Leber ist bereits 
anatomischer Ausdruck ihrer zentralen Funktion als Stoffwechselorgan des 
Menschen: zu ihren Aufgaben gehören zum Beispiel die Herstellung von 
Glucose, Cholesterin und körpereignen Eiweißen; die Speicherung von Zuckern, 
Fetten und Vitaminen; die Beiteiligung an der Verdauung über die Produktion von 
Gallensäuren sowie der Abbau und die Entgiftung von Stoffwechselabfällen und 
zugeführten Stoffen wie Alkohol oder Medikamenten. 
Unterstützt wird die Leber  bei der Verstoffwechselung der Nahrung unter 
anderem von Bakterien im menschlichen Darm, welche entscheidend die Art und 
Zusammensetzung der aufgenommen und von der Leber weiterverarbeiteten 
Stoffe prägen. Die Rolle des in seiner Komplexität noch relativ unverstandenen 
Microbioms erscheint als ein neuer Ansatzpunkt in der hepatologischen 
Forschung und um unser Verständnins des Zusammenspiels von Leber und 
Darm zu erforschen, wurden in den letzten Jahrzehnten immer mehr 
wissenschaftliche Arbeiten angefertigt- in dieser Reihe will sich diese Arbeit 
eingliedern.  
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Clostridium sporogenes, ein physiologisch in der Darmflora des Menschen 
vorkommender Bakterienstamm, wurde von Wikoff et al. als alleiniger Produzent 
des antioxidativen Stoffes Indole-3-propionic acid (IPA) entdeckt. Ohne den 
Ursprung von IPA zu kennen, konnte Chyan et al. bereits in primären Neuronen 
erfolgreich einen protektiven Effekt gegen oxidativen Stress nachweisen. 
 
In dieser Arbeit soll nun auf den Effekt von IPA auf primäre Hepatozyten 
eingegangen werden und eine potentielle symbiotische Regulierung des 
hepatozytären Metabolismus durch einen bakteriellen Stoff erforscht werden. 
 
Methodologisch wurde eine primäre, murine Hepatozytenkultur einem 
etablierten, auf Chlorkohlenwasserstoff basierenden Zellschädigungs-Schema 
unterzogen. Eine quantitative und qualitative Analyse der Zellschädigung und 
Protein Expression auf zellulärer Ebene sollte Aufschluss über den möglichen 
Einfluss von IPA auf die Leberzelle geben.  
 
Eine vermutete protektive Eigenschaft von IPA in der Leberzelle im Sinne eines 
Schutzes vor intrazellulärem oxidativem Stress konnte indirekt mittels einer 
signifikanten Verminderung der intrazellulären Oxidierung von Fetten bestätigt 
werden. 
Eine durch Chlorkohlenwasserstoff ausgelöste Nekrose bzw. Zellschädigung der 
Hepatozyten konnte durch IPA signifikant und Dosis-abhängig vermindert 
werden, was durch mikroskopische Evaluation und durch Markerenzyme 
nachgewiesen wurde. 
Mittels Western Blot und densitometrischer Quantifikation kann auch eine 
potentielle Induktion von bestimmten Enyzmen (HSP27 und SOD1) durch IPA 
vermutet werden. 
 
In Bezug auf den Stand der Forschung konnte die protektive, dosis-abhängige  
Eigenschaft des bakteriellen IPA erstmalig in primären Hepatozyten 
nachgewiesen werden. Die Induktion der Proteine HSP27 und SOD1 konnte in 
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Bezug auf Erkenntnisse der Arbeitsgruppe um Sakurai et al. als ambivalent im 
Sinne einer oxidativen Stress reduzierenden aber potentiell cancerogenen 
Wirkung kategorisiert werden. Diese Eigenschaft scheint IPA aufgrund des 
unklaren Ausmaßes an Induktion der Enzyme jedoch nicht grundsätzlich als 
potentielles Heilmittel zu disqualifizieren und weitere Langzeituntersuchung 
sollten an die durchgeführte Versuchsreihe angeschlossen werden. Jedoch ist 
die vorläufige Einschätzung des sehr wirksamen Antioxidants IPA mittels 
weiteren Ergebnisse zur Kanzerogenität zu überprüfen. 
 
 
2 Introduction 
 
 
The liver is the largest gland in the human body, representing 2.5% of the 
absolute body weight. It provides a multitude of metabolic functions that are 
fundamental to sustaining physiological homeostasis.1 
 
The liver parenchyma consists of numerous liver lobules that contain 
hepatocytes and nonparenchymal liver cells, including Kupffer cells (KC), 
sinusoidal endothelial cells (SEC) and hepatic stellate cells (HSC). The unique 
parenchymal architecture of the liver lobules is modelled by hepatocytes, and 
their central role in liver physiology is underlined by their involvement in most of 
the liver’s many functions.2 
 
Most of the liver’s blood supply comes from the intestine through the portal vein. 
This unique blood supply configuration makes the liver a central junction for the 
interplay between mammalian and bacterial metabolism. When intestinal 
permeability increases, the translocation of bacterial-derived products to the liver 
via the portal vein occurs.3 For example, intestinal dysbiosis and bacterial 
translocation (BT) are common in patients with advanced liver disease, and the 
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translocation of bacteria contributes to alcoholic liver disease (ALD), whereas 
bacterial decontamination improves alcoholic liver disease.4-6 
 
Central to this pathophysiological and most probably lipopolysaccharide (LPS)-
mediated impact is the signalling via pattern recognition receptors, precisely the 
toll-like receptor family (TLR), which recognize bacteria-derived products and 
activate innate immune response.7 
 
Activated HSC and KC maintain hepatic injury in liver fibrosis, steatohepatitis, 
and insulin resistance8 by secreting inflammatory mediators. The activation is 
triggered by the interplay of bacterial products and the TLRs.9 
 
In contrast to the focus on BT and intestinal barrier failure contributing to hepatic 
diseases, a new paradigm of a liver-gut axis has been formulated. Intriguing 
questions about the symbiosis of the gut microbiome and the liver remain 
unanswered.10,11 
 
In a study that compared the plasma of germ-free mice and the plasma of 
conventional mice, findings based on a broad mass spectroscopy metabolomics 
study (conducted by Wikoff et al.) suggest an unexpectedly large effect of the 
microbiota on mammalian blood metabolites. 12 
 
Recently, Mazagova et al. made the novel observation that the microbiome is 
necessary for liver homeostasis, and an absence of bacteria and their products 
lead to escalated fibrosis upon hepatotoxin-induced chronic liver injury.11  
One mechanism of hepatic protection that may be involved appears to be a direct 
targeting by bacterial metabolites.  
 
Some amino acids are described as bacterial metabolites. The production of the 
indole-containing, melatonin-like metabolite Indole-3-propionic acid (IPA) was 
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recently discovered to be completely dependent on the presence of Clostridium 
sporogenes.12-14 
 
Subsequently, the greater susceptibility of hepatocytes in germ-free mice to cell 
death following TAA treatment (Mazagova et al.) was hypothesized as a 
consequence of the absence of bacterial-derived IPA.  
 
Furthermore, bacterial-derived IPA has recently been found to serve as a ligand 
for the xenobiotic sensor pregnane X receptor (PXR). PXR-deficient mice show a 
distinctly leaky gut as well as an upregulation of the toll-like receptor signalling 
pathway. In vivo IPA downregulated enterocyte-mediated inflammatory cytokine 
and enterocyte tumor necrosis factor-α (TNF-α). At the same time, it upregulated 
junctional protein-coding mRNAs in enterocytes.15,16 
 
In line with this concept of symbiosis and the inherent idea of microbiome cross-
talk to the gut and liver promoted by their close proximity, investigations of the 
biochemical details of the liver-gut axis were further encouraged by 
interdisciplinary results of neurologic research. 
Emerging evidence suggests that intestinal homeostasis and the microbiome are 
playing a considerable role in neurological diseases. For instance, in 
amyotrohphic lateral sclerosis (ALS), a decreased level of antimicrobial 
defensines, which are produced physiologically in Paneth cells and help shape 
the microbiome, seem to be involved in the disease progression.17  
Reactive oxygen species (ROS) are central to the onset of a variety of chronic 
diseases such as Alzheimer`s, Parkinson`s, ALS, and other neurological 
diseases that are caused by increased ROS levels.18 
Chyan et al. found the bacteria-derived indoleamine IPA, which has been 
detected in the cerebrospinal fluid of humans, to completely protect primary 
neurons from oxidative stress, such as that caused by the amyloid beta-protein in 
Alzheimer`s disease. Chyan et al. focused on the radical scavenging capacity of 
IPA, which was found to even surpass the antioxidant potential of melatonin.19 
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In reviewing the literature, data was found that IPA has not only neuroprotective 
properties but protective effects on hepatic microsomal membranes incubated 
with iron-induced oxidative stress.19,20 
 
This study is designed to test the hypothesis of a protective effect of IPA on 
primary hepatocytes in vitro and wants to clearify the potential of IPA as new 
drug in hepatologic disorders. Derived from current research results a first proof 
of hepatoprotective effect shall be followed by investigations on the concept of 
hepatoprotective mechanisms of IPA. 
3 Material and Methods 
3.1 Microscopy 
 
All microscopy was performed with a combined light and fluorescent microscope 
(Olympus  IX71 Microscope, USA). Images presented in this study were captured 
with this microscope. 
 
3.1.1 Trypan Blue 
 
The commonly used Trypan Blue dye exclusion test is based on the principle of 
viable cells excluding dyes such as Trypan Blue. Indeed, dead cells do become 
permeable for the dye and take it up. Trypan Blue Stain (0.4%, GIBCO) was 
used to calculate the viability of isolated primary hepatocytes in this study. 
 
3.1.2 Fluorescent dyes 
 
To evaluate the physiological status and to detect living, dead, and apoptotic 
cells, primary hepatocytes were stained with fluorescent dyes. 
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3.1.2.1 Hoechst 
 
Cells were stained with the DNA-binding dye Hoechst 33258 (Invitrogen, 
Carlsbad, CA) after treatment with carbon tetrachloride (CCl4). Hallmarks of 
apoptosis, including nuclear condensation, chromatic margination, and 
fragmentation, were then appraised.21,22 
 
3.1.2.2 Propidium Iodide 
 
Degradation of internucleosomal DNA in apoptosis correlates with the intensity of 
staining with a DNA-adhering fluorescent dye such as Propidium Iodide 
(Propidium Iodide, Sigma, USA), which can be useful in quantifying DNA 
degradation and apoptosis in cells.23,24 
 
 
 
3.2 Cell isolation 
 
Today, isolation of hepatocytes is a basic method used in liver research25 that  
enables investigators to evaluate liver function in vitro. Primary hepatocytes have 
proven to provide a significantly better replication of liver organ function 
compared to immortalized cell lines when cultured.26  
 
The technique described in the following paragraph was developed by Berry and 
Friend in 196927 and has undergone many modifications.28,29 In a surgical 
procedure, a liver as a whole organ is resected and hepatocytes are released. A 
two-step collagenase perfusion is performed, in which the physiological liver 
architecture is disbanded by enzymatic digestion. A non-recirculating perfusion 
through the portal vein was used in this study. 
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The hepatocytes were separated from the remaining cells by filtration and 
centrifugation. The success of the isolation procedure can be assessed by light-
microscopy via dye-exclusion of viable cells.  
 
 
3.2.1 Animals 
 
Male wild-type C57BL/6 mice were purchased from Charles River (Wilmington, 
MA, USA) and bred in a vivarium at the UCSD Biomedical Research Building 
(Leichtag-Building), in San Diego, in a specific pathogen-free (SPF) environment. 
All animals were nurtured with a standard diet and had drinking water ad libidum. 
The age of the animals used in the study ranged from at least 6 weeks to a few 
months. 
 
 
3.2.2 Procedure 
 
The hepatocytes used in the study were obtained using the following procedure: 
(1) preparation of the perfusion liquids, operating room, and anaesthesia; (2) the 
mouse surgery is performed with intraoperative liver perfusion, removal of the 
liver, and harvesting of hepatocytes; and (3) quality control is conducted. 
 
3.2.2.1 Preparation of two-step collagenase digestion 
 
Cell isolation is a delicate process that needs to be performed accurately to 
guarantee an optimal result. The perfusion buffers for the two-step collagenase 
digestion were stock preparations of SC1 and SC2. 
All the chemicals listed in table 1 were weighed with an analytical balance (AB54-
S, Mettler Toledo, Switzerland) and, along with CaCl2 × 2H2O that was added just 
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before use, added to water to generate the final concentrations of the stock 
solutions.  
To adjust both aqueous solutions to physiological pH-values to ensure the 
optimal acidity for the digesting enzymes, the pH was adjusted to 7.35 using an 
electronic pH meter (Accumed BASIC AB15, Fisher, USA).  
Subsequently, both solutions where filtered in a sterile manner using a 0.22µm 
filter (Steritop, vaccuumdriven, 0.22µm, Millipore, USA) and stored at room 
temperature until use.   
Prior to commencing the procedure, the perfusion buffers SC1 and SC2 were 
stored in autoclaved bottles. 
 
Regarding the time-dependent enzyme activity of the used collagenases and the 
vulnerability of hepatocytes, precautionary measures were taken as described in 
the following paragraph. 
The bottles were kept in a 42°C water bath during the whole procedure to maintain 
an adequate temperature of 37°C when entering the organ after passing through 
the plastic tubing system.  
The SC2 was already warmed in a water bath, and shortly before use, the digestion 
enzymes were put into solution and CaCl2 × 2H2O was added at the concentration 
given in table 1. To confirm that an ample and standardized enzyme activity was 
occurring, the solution was used no later than 30 minutes after dissolving the 
collagenases. The enzymes used for digestion were Collagenase P (produced in 
Clostridium histolyticum, Roche, USA), which has an enzyme activity of 1.74 U/mg 
in a concentration of 50mg/l, and Collagenase D (produced in Clostridium 
histolyticum, Roche, USA) which has an enzyme activity of >15 U/mg in a 
concentration of 500 mg/l.  
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Table 1: Recipe of SC-1 and SC-2  
 
 SC-1 SC-2  
 
NaCl2 8000mg/l 8000mg/l 
KCl 400mg/l 400mg/l 
NaH2PO4.H2O 78mg/l 78mg/l 
Na2HPO4 120.45mg/l 120.45mg/l 
HEPES 2380mg/l 2380mg/l 
NaHCO3 350mg/l 350mg/l 
EGTA 190mg/l (-) 
Glucose 900mg/l (-) 
CaCl2 × 2H2O (-) 560mg/l  (just before use) 
 
 
 
3.2.2.2 Liver perfusion in situ 
 
 
 
In order to extract vital hepatocytes, a two-step collagenase digestion was 
performed in situ. Retrograde perfusion of the liver first with SC1 followed by SC2 
through a perfusion system entering the portal vein was conducted. The liver was 
removed as a whole organ and transferred to a sterile cell culture hood 
(SterilGardHood Class II, the Baker Company, USA). 
 
Mice were anesthetized using an isotonic solution (BBL Saline, Normal, 10ml, 
BD, USA) containing 1% xylazine (AnaSed Injection, c=100mg/ml Xylazine-
Hydrochlorid, LLOYD, USA) and 6% ketamin (KetaSet C3, c=100mg/ml Ketamin, 
Fort Dodge Animal Health, USA). After 0.4ml of anaesthetics were applied via 
intraperitoneal injection, consciousness was tested repeatedly.  
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The abdomen was prepared with 70% ethanol-solution in order to ensure 
sterilization of the operating area for the surgical procedure. With a midline 
incision of the abdominal skin, the abdominal cavity was opened. The portal vein 
was exposed by gently moving the viscera to the side with a sterile cotton bud. 
Next, a sterile 20-gage catheter (Safelet Cath, 20G x 1”, EXEL, USA) was 
inserted in the inferior vena cava (IVC) and fixed with surgical string (0.7 metric, 
45cm, Henry Schein, USA). The intravenous catheter was connected to the 
tubes of the perfusion system, which included a pump (Masterflex, Modell 7518-
00, Cole Parmer Inc., USA), plastic tubes, and a 42°C water bath for the SC1 
and SC2 solutions. A filter (25mm Syringe Filter, 0.2 µm, Fisherbrand, USA) was 
placed in between the catheter and the tubes.  
 
Perfusion was started with SC1 with a flow rate of 10ml/min for 5 minutes. As 
soon as the liver macroscopically started to change color (caused by blood 
drainage, indicating a correct cannulation and adequate position of the catheter), 
the hepatic portal vein was cut to allow efflux and to prevent portal hypertension. 
Directly after efflux of the perfusion buffer via the portal vein was evident, a 
thoracotomy was performed and the diaphragm was cut to expose the superior 
vena cava  (SVC), which was carefully blocked with surgical tweezers to allow 
more efficient perfusion of the liver.  
Next, the perfusion was continued after switching to the SC2 solution. The liver 
became swollen and pale, indicating that the perfusion was carried out 
successfully. To estimate the degree of parenchymal digestion, touching the 
organ with a sterile cotton bud tested its turgor and provided a clue for 
determining the perfusion endpoint. Hepatectomy was carried out cautiously after 
5 to 8 minutes of perfusion with SC2 when digestion was completed. Finally, the 
liver was transferred to a sterile 100mm Petri dish containing 30ml of SC2 at 4°C, 
and subsequent work was performed under the cell culture hood. 
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3.2.2.3 Isolation of Hepatocytes 
 
Liver cells were further processed in a gentle manner, taking their vulnerability 
into consideration. Vital hepatocytes for cell culture were purified by washing, 
filtration, and centrifugation. 
Once placed in the Petri dish, the capsule of the extracted liver was opened with 
sterile forceps, and cells were allowed to disperse into the SC2 at 4°C. Cell 
dispersion was filtered through a 70µm pore-size cell strainer (Nylon Cell 
Strainer, BD Falcon, USA) into a 50ml conical tube. Connective tissue and 
undigested tissue fragments remained in the filter, and cells were resuspended in 
40ml of SC2 at 4°C. To separate the vital from dead cells, centrifugation (Allegra 
6R Centrifuge, Beckmann Coulter, USA) was performed twice at 450rpm for 1 
minute at 4 °C. After the first centrifugation, the supernatant was carefully 
removed by vacuum and cells were gently resuspended by washing with media 
(Media 199 without Phenolred, Gibco, USA). Finally, the hepatocytes were 
resuspended a second time with 25ml of media containing 10% Fetal Calf Serum 
(FCS, Sigma-Aldrich, USA) at 37 °C. 
 
3.2.3 Quality control: viability 
 
Viability was one of the main criteria for quality control of the isolated cells. 
Trypan Blue Stain 0.4% (GIBCO, USA) was used to distinguish dead cells as 
described in section 3.1.1.  
Due to loss of cell membrane integrity of dead hepatocytes, Trypan Blue stained 
them. Each 10µl of primary hepatocyte suspension and Trypan Blue were mixed 
(directly after the isolation) and counted in a counting chamber (Bright-Line 
Hemacytometer SET, Hausser Scientific, USA) using light microscopy. Total 
viablility (V) was calculated by ratio of vital cells (vc) to total cells counted(tc) (V= 
vc/tc  x 100). 
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3.3 Primary cell culture 
 
The hepatocytes were plated, and cellshape and confluency were monitored 
microscopically. An adequate environment for primary hepatocytes was 
confirmed, and the medium was adapted as needed for the experimental 
setting.30 
 
Cells were plated in 6-well Multiwell Plates (Tissue-culture treated polystyrene, 
flat bottom, low-evaporation lid, BD Falcon,USA) pre-coated with collagen. In 
order to pre-coat each well, a solution containing 30% ethanol and rat collagen 
type 1 (Collagen Type 1, Rat Tail, BD Biosciences, USA) was produced. 
Subsequently, in total 22.18 µg of collagen per well were dispensed within the 
solution and the solution was distributed equally in each well (by placing the 
plates on a shaker at high speed). Afterwards, plates were stored under the hood 
and air dried with the lid open for at least 30 minutes to facilitate the complete 
evaporation of the alcoholic components. 
The total number of cells collected during isolation was calculated using a cell 
counting chamber. These values typically ranged from 20 x106 to 30 x106. In 
each well, 9x105 primary hepatocytes26 were seeded in 2ml of Medium 199 
(Medium 199 without Phenolred, GIBCO, USA) that contained 10% FCS and 1% 
antibiotics (Antibiotic-Antimycotic 100X, Life Technologies, USA). Cells were 
allowed to attach for 2h in an incubator,30 which maintained a 37°C temperature 
and an air-humidified atmosphere with 5% CO2. Cell confluency was monitored 
with a light microscope and was typically higher than 90%. After an attachment 
period of 2h, the medium was replaced by 2.0ml of serum-free Medium 199.   
 
3.4 Cytotoxicity model  
 
Cytotoxicity models are frequently used in drug studies. Of major interest are 
metabolites of drugs and their toxicity.  
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In contrast to other immortalized hepatic cell lines, primary hepatocytes have the 
capacity for biotransformation in vitro25 and, supported by the strategies 
discussed in section 3.3, are able to maintain their metabolizing activity for a 
longer time period.31 
Corresponding to the property of CCl4 (as a haloalkane) to have a toxic impact 
on cells by means of bioactivation, primary hepatocytes can be targeted very 
exclusively, both in vivo and in vitro. Particularly for short-term experiments in 
vitro, primary hepatocytes are described in the literature as being able to 
maintain a stable gene expression level of relevant enzymes for bioactivation.31  
 
Once CCl4 was metabolized and the CCl3* radical arose, several mechanisms 
were seen to have a toxic impact on hepatocytes.32 The cumulative effect as well 
as the exclusive impact mediated by lipid peroxidation was measured in this 
study using several methods such as detecting enzyme leakage, identifying 
oxidative stress levels, and ascertaining cell death through the microscope.  
 
The pivotal idea to investigate the hepatoprotective effect of IPA required the 
establishment of CCl4-induced cell damage. 
 
 
3.4.1 Indole-3-propionic acid (IPA) 
 
Because IPA is a bacterial-derived compound with varying physiological plasma 
levels in mammalians, the concentration of IPA in solution used in this study was 
ranged mostly from 0.1µM to 1µM. 
 
To produce the solution, 0.5mg of IPA stock powder (MP-Biomedicals, USA) 
were dissolved in 50ml of distilled water. To guarantee a complete dissolving 
process, sodium hydroxide (c=10M) was added cautiously. Next, the pH was 
adjusted to 7.00, and the IPA solution was stored at 4°C and protected from light 
(due to the indole-containing chemical structure as shown in picture 1). 
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Picture 1: structural formula of indole-3-propionic acid (IPA) 
 
 
3.4.2 Carbon tetrachloride (CCl4) 
 
To study hepatoprotective effects on primary hepatocytes in vitro, cell damage 
was induced with hepatotoxic carbon tetrachloride (carbon tetrachloride, reagent 
grade, 99.9%, 319961 Sigma-Aldrich, USA) within the cell culture.  
 
In the first phase, the cytotoxicity model had to be established. In the second 
phase, after robust reproducibility of results had been assured, the cytotoxicity 
model was implemented and valid data could be assessed. Basically, to induce 
cytotoxicity, CCl4 was added in a concentration of 10mM to the cell culture. 
 
 
The haloalkane Carbontetrachloride (CCl4) is a colourless liquid characterized by 
the data sheet given in table 2 (from the producer, Sigma-Aldrich). 
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Table 2: Data sheet of CCl4 according to Sigma-Aldrich 
 
 
ACS grade    reagent grade  
Vapor density    5.32 (vs air)  
Vapor pressure    143 mmHg ( 30 °C)  
   91 mmHg ( 20 °C)  
Assay    99.9%  
Refractive index    n20/D 1.460(lit.)  
Boiling-point    76-77 °C(lit.)  
Melting-point    −23 °C(lit.)  
Density    1.594 g/mL at 25 °C(lit.)  
 
 
While performing experiments with CCl4, strict safety guidelines had to be 
followed. All safety instructions for the use of CCl4 suggested by the 
manufacturer`s were followed. 
 
 
3.4.2.1 Phase 1 
 
The experimental design was set up based on consideration and evaluation of 
criteria including the time points of sufficient cell damage induction, the 
necessary but balanced dose of CCl4, and the influence of serum in the culture 
medium. The cytotoxicity model was established using this methodological 
approach, and the latest literature was consulted. 
 
As outlined in section 3.2.2, isolated primary hepatocytes were plated in 6-well 
plates, and after 2h of plating, the medium was changed. Phase 1 experiments 
were performed changing some wells to Medium 199 containing 0% FCS and 
some to Medium 199 containing 10% FCS. 
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Following standard procedures found in the literature,33 CCl4 was diluted to 
concentrations of 5mM, 10mM, and 25mM by adding the CCl4 stock solution to 
the medium in an airtight, lockable, and sterile 50ml conical centrifuge tube 
(Falcon™ 50ml Conical Centrifuge Tube; Fisher Scientific; USA) directly before 
use (i.e., directly before adding the new medium to the cell culture well) and 
shook strongly to support the troublesome dissolving process of CCl4. Medium 
199 containing CCl4 and either 0% or 10% FCS  was added with sterile 5ml 
serological pipettes (Corning Costar Stripette, Sigma Aldrich, USA) to the wells 
with plated hepatocytes. In a literature review, timepoints of 6h and 24h (after 
adding media containing CCl4) were found be suitable for the needs of this study. 
With this choice, interference from non-parenchymal cells was also taken into 
consideration.34,35  
 
Finally, 200µl of supernatant was saved for enzyme measurement. The opening 
of the Eppendorf Pipette tip was placed so that it did not touch the well’s wall and 
was located just beneath the surface of the medium so as not to interfere with the 
cultured cell monolayer on the bottom of the well. The evacuated supernatant 
was transferred to capped 1.5ml tubes on ice, and enzyme levels were measured 
as described in section 3.4.3.  
 
3.4.2.2 Phase 2 
 
The preparatory experiments in phase 1, results shown in section 4.2, helped to 
establish a setup with defined criteria for the cytotoxicity model, and the standard 
operating procedure (SOP) was maintained as shown in picture 2. A promising 
configuration for further experiments was defined: a concentration of 10mM CCl4, 
Medium 199 containing 0% FCS and a 24h-treatment period of hepatocytes 
(compare figures 1 and 2).  
In order to fulfil the research community`s standards of replicability in 
experiments, each hepatocyte´s treatment was repeated in three wells per 
isolation, and the mean value of the triplicates was used for further data analysis. 
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Picture 2: Schematic sequence of events defined as standard operating  
                 procedure in the cytotoxic model 
 
 
3.4.3 Enzyme leakage 
 
In cytotoxicity evaluation, enzyme leakage of cell cultures in vitro is a commonly 
used approach.  Lactate dehydrogenase (LDH) and alanine aminotransferase 
(ALT) are primarily of cytosolic origin.36 The detection of enzyme leakage is 
performed using a Absorbance-reading device (VersaMax™ ELISA Microplate 
Reader, Molecular Devices, USA) and corresponding software (SoftMax Pro, 
Molecular Devices, USA). 
 
 
3.4.3.1 ALT 
 
ALT enzyme levels were measured in the supernatant with standards from 
Document Enzyme Linearity Test Set (Document Enzyme Linearity Test Set, 
Microgenics Casco Standards, USA). 
Plating (10% FCS)        Cytotoxic   Model  (0%FCS)  
Start 
 t=0h 
 
 
End 
t=24h 
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The applied method for determining ALT was based on recommendations of the 
International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) 
and was essentially developed by Bergmeyer,37 in order to optimize substrate 
conditions and eradicate side reactions. Linearity of the assay was provided up to 
450 U/l depending on the sample-reagent volume quota and the timing of the 
measurement. 
In any ALT measurement, a standard volume of 200µl supernatant from the 
primary hepatocytes culture was processed. The supernatant was transferred on 
ice and centrifuged for 2 minutes in order to gather the incidentally aspirated cells 
into a pellet at the bottom of the tube. With the carefully aspirated 150µl of cell 
free supernatant, quantitative determination of ALT enzyme levels was 
conducted. 
 
The Infinity ALT Reagent (Infinity ALT (GPT) Liquid Stable Reagent, Thermo 
Scientific, USA) and optically clear 96-well flat-bottom microplates for 
absorbance and colorimetric assays were used.  Considering the practical 
challenges caused by the time-dependent character of the enzyme measurement 
method, 200µl of Infinity ALT Reagent was added to each 20µl of sample 
contemporaneously using a multi-pipette. In principle, the quantification of ALT 
enzyme activity in the samples is based on indirect observation. The kinetics of 
the coenzyme Nicotinamide adenine dinucleotide (NAD) is measured on the 
basis of changes in the absorbance of light (with a wavelength of 340nm; details 
are shown in tables 2 and 3). During an initial incubation period after mixing the 
samples with the Infinity ALT(GPT) Liquid Stable Reagent, the endogenous 
pyruvate of the samples was rapidly metabolized by LDH. This was anticipated 
by the producer of the reagent, and offers the advantage of eliminating possible 
inaccuracy. 
 
LDH: 
Sample Pyruvate+ NADH        —————>        L-Lactate + NAD 
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After a short initial incubation period, any changes of absorbance during the 
subsequent measurement period are caused by the slower ALT reaction (see 
section 3.4.3.2) and a subsequent increase in NAD. This can be described in the 
sequence of the following two enzymatically mediated reactions: 
 
 
1. ALT: 
L-Alanine + 2-Oxoglutarate      —————>         Pyruvate + L-Glutamate 
 
2. LDH: 
Pyruvate+ NADH                      —————>         L-Lactate + NAD 
 
 
 
 
 
Table 2: Reagent Composition of Infinity ALT(GPT) Liquid Stable Reagent 
 
 
Active Ingredients     Concentration 
2-Oxoglutarate     13 mmol/l 
L-Alanine      440 mmol/l 
NADH      > 0.12 mmol/l 
LDH (microbial)     > 2000 U/l 
Tris Buffer      97 mmol/l 
EDTA      5.0 mmol/l 
pH       7.80 ± 0.10 at 20°C. 
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Table 3: System parameters of Infinity ALT(GPT) Liquid Stable Reagent 
 
 
Temperature     37°C 
Primary Wavelength    340 nm  
Assay Type      Rate/Kinetic 
Direction      Decrease 
Sample : Reagent Ratio    1 : 10 
used Sample Vol     20 μl 
used Reagent Vol     200 μl 
Delay/Lag      30 seconds 
Read Time      1 to 3 minutes 
Linearity      450 U/l 
 
 
 
3.4.3.2 LDH 
 
LDH is a stable cytoplasmic enzyme that is present in all cells. Due to the 
affection of cell membrane integrity, LDH is released into the supernatant of the 
cell culture. LDH activity (Michaelis constant of periportal LDH in the literature38: 
KM(LDH) = 8.62-13.5 mmol x l
-1) in the supernatant was assessed with the 
Cytotoxicity Detection Kit (LDH, Roche, USA) based on the enzyme kinetic 
properties of LDH. 
 
After cytotoxicity experiments were performed according to the established 
model described in section 3.4.2.2, 100µl of cell-free supernatant was transferred 
to an optically clear 96-well flat bottom microplate well for absorbance and 
colorimetric assays. To every well containing a sample, 100µl of freshly prepared 
reaction mixture was added at room temperature. During the 30-minute 
incubation period, the microplate was protected from light.  
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To measure the LDH activity, a spectrophotometric microplate reader captured 
absorbance at a wavelength of 492nm. Corresponding to pictures 3 and 4 the 
relationship between LDH activity and absorbance is directly mediated by the 
amount of formazan formed during a specified time period. 
 
 
 
     (……)  absence of LDH 
(------) presence of LDH 
 
 
Picture 3:  Absorbance spectra of the working solution of the Cytotoxicity  
Detection Kit added in RPMI 1640 with 1% BSA as published by  
Roche. (Source: Cytotoxicity Detection Kit (LDH) Manual Version 
08) 
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Picture 4:  Two-step LDH-mediated reaction with endpoint formazan and  
coenzyme NAD are shown as published by Roche. (Source: 
Cytotoxicity Detection Kit (LDH) Manual Version 08) 
 
 
 
 
3.4.4 Oxidative stress 
 
Oxidative stress caused by CCl4-initiated radical chain reactions leads to lipid 
peroxidation. The lipid peroxides are unstable indicators of oxidative stress. 
Therefore the approach was to measure the aldehydic secondary products of 
lipid peroxidation as Malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) by 
quantifications of their adducts with thiobarbituric acid (TBA).32  
The oxidative stress was quantified using the OxiSelect™ Thiobarbituric Acid 
Reactive Substances (TBARS) Assay Kit (Cell Biolabs Inc., USA). 
 
According to the TBARS Assay Kit´s protocol, the cell cultures were treated and 
standardized following the SOP (see section 3.4.2.2). Cell cultures were 
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harvested from the 6-well plate with 300µl ice-cold phosphate buffered saline 
(PBS) using a cell scraper. Next, the cultures were centrifuged in a 1.5ml tube for 
5 minutes with 600g at 4°C, and finally they were resuspended with PBS 
containing 0.05% butylated hydroxytoluene (BHT) for ultrasonic comminution 
conducted on ice. The whole homogenate was further used in the assay. A 
standard curve was produced using Malondialdehyde bismethylacetal (MDA) 
ranging from 0M to 125µM (see table 4). Cell homogenate was also treated with 
SDS Lysis Solution for 5 minutes at room temperature in order to disrupt the cell 
membranes. Each cell homogenate was incubated with TBA Reagent in the 
heatblock at 95°C for 45 to 60 minutes and cooled again on ice to room 
temperature. Samples were centrifuged again at 3000rpm for 15 minutes and 
supernatant was collected for extraction of TBARS by butanol (n-Butanol, Sigma-
Aldrich, USA) to prevent interference with hemoglobin and its derivates. 
Fluorescence measurement was performed using black 96-well flat bottom 
microplates for fluorescent assays. The fluorescence of duplicates of both 
samples and standards were measured as recommended by the manufacturer`s 
instructions. 
 
 
Table 4: MDA Standard - Curve 
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3.5 Western Blot 
 
The Western Blot technique was described separately by Renart and Towbin in 
1979.39,40 The protein is presented on a nitrocellulose paper and can be stained, 
allowed to react with antibodies, and be cleaved proteolytically or chemically.41 
 
3.5.1 Homogenization of protein extracts 
 
Directly after the incubation period, the lysate from the cell cultures was 
produced.  
The hepatocyte culture dish was transferred from the incubator to ice and  
washed twice with ice-cold PBS. Adherent cells were scraped off the well’s 
bottom and prepared for Western Blot analysis with the lysis buffer Dignam C 
(see table 5) containing freshly added Protease (Roche) and Phosphatase 
inhibitors (Sigma). This is done to disrupt cell membrane, solubilize intracellular 
proteins, and slow down the proteolysis, dephosphorylation, and denaturation 
that usually occur after lysis. 
 
 
Table 5: Recipe of lysis buffer Dignam C 
 
HEPES pH 7.9    10mM 
NaCl     0.42M 
MgCl2     1.5mM 
DTT      0.5mM 
Glycerol     2.5ml 
NP-40     50µl 
ddH2O     6.49ml 
Proteinase inhibitor    1 tablet 
Phosphatase inhibitor (100x) 10 
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3.5.2 Protein concentration 
 
Protein concentration was assessed using the common bicinchoninic acid (BCA) 
assay (Pierce™ BCA Protein Assay Kit, Thermo Scientific, USA).42,43 The assay 
is based on the reduction of copper (Cu2+ to Cu+) and is followed by BCA 
chelation as well as complex formation. This reaction results in a color change 
from green to purple, which can be measured photometrically with absorbance at 
a wavelength of 560nm.44 
 
With the BCA standards ranging from 0 to 10 µg/l, the protein concentration of 
the samples was determined by linear regression. Therefore, standards and 
samples were run in duplicates on the same optically clear 96-well flat-bottom 
microplate for absorbance and colorimetric assays. 
In preparation for the assays, 200µl BCA Protein Assay Mix was added to 5µl of 
homogenates of the cell culture extracts with the multi pipette. After an incubation 
period of 30 minutes at 37°C, absorbance was measured and protein 
concentration calculated for further experiments. 
 
 
3.5.3 Gel production 
 
The separating gel was mixed, according to the protein size of interest, as 
described in tables 6 and 7. 
 
In detail, glass frames for polyacrylamide gels were prepared by cleaning two 
10cm x 10cm pieces of glass plate  with 70% ethanol. The plates were 
assembled with spacers in between. Next 80% of the space in the frame was 
filled with separating gel, and the height of the solution was marked on the 
outside of the frame. TEMED (Tetramethylethylenediamine, Sigma-Aldrich, USA) 
and 10% APS (Ammonium Persulfate , Sigma-Aldrich, USA) start the 
polymerisation of Acrylamide and were added just before use. To produce an 
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even surface on the separating gel, 0.3ml of ddH2O was added carefully in a thin 
continuous separating line on top of the separating gel solution after the upright 
standing glass frame was filled. When the polymerization was finished, ddH2O 
was finally shed off.  
The stacking gel was produced following a recipe: 3.2ml ddH2O, 1.25ml 0.5M 
Tris (Tris-buffered saline, Sigma, USA) pH 6.8, 50µl 10% SDS (sodium dodecyl 
sulfate, USA), and 0.5ml Acrylamide 40% (Acrylamide 40%, USA). The gel was 
mixed, and just before use 25µl of 10% APS and 10µl of TEMED were added.  
 
The stacking gel was poured carefully onto the already solidified separating gel 
and a 14-tooth comb was inserted into the stacking gel solution. After the gels 
were solidified completely, the glass frame with the gels was fit into an 
electrophoresis chamber. The comb was removed carefully to create undamaged 
pockets, which were checked by rinsing the pockets with a running buffer 
solution (containing Tris, Glycine, and SDS). The electrophoresis chamber was 
filled with running buffer solution.  
 
 
 
Table 6: Acrylamide percentage dependent on size of protein of interest 
 
Percentage 
Acrylamide 
Protein 
Size 
 
15% <17kDa 
12% 17–30kDa 
10% 30–70kDa 
7.5% 70–94kDa 
5% 94–
212kDa 
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Table 7: Content of separating gel dependent on protein size (compare table 6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.5.4 Electrophoresis 
 
In gel electrophoresis proteins are separated by size. To prepare proteins for 
SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis), 
Loading Buffer (NuPAGE LDS Sample buffer (4X), Life Technologies, USA) was 
added to the samples and they got denatured and coupled with negative charge 
by means of 5 minutes heating at 95°C in a heatblock. The amount of sample 
protein was set as 50µg of proteins per pocket. Therefore, a corresponding 
volume of the sample protein was calculated after measuring the protein 
concentration (as described in section 3.5.2) and added to a capped 1.5ml tube. 
Subsequently, proteins were added carefully to the gel pockets. Additionally, one 
pocket was loaded with 5µl of PageRuler Ladder (Page Ruler Prestained Protein 
Ladder, USA) to help determine the size of the sample proteins. 
In the electrophoresis process, voltage was first set to 110V. When the 
PageRuler Ladder reached the marked borderline of stacking and separating gel, 
the voltage was upregulated to 130V until the lowest molecular-weight marker 
reached the bottom of the gel. 
Separating Gel 15% 12% 10% 7.5% 5% 
ddH2O 3.5mL 4.3ml 4.8mL 5.4mL 6.1mL 
1.5M Tris pH 8.8 2.5mL 2.5mL 2.5mL 2.5mL 2.5mL 
10% SDS 100µL 100µL 100µL 100µL 100µL 
Acrylamide 40%  3.8mL 3mL 2.5mL 1.9mL 1.25mL 
Add right before 
use: 
     
10% APS 50µL 50µL 50µL 50µL 50µL 
TEMED 20µL 20µL 20µL 20µL 20µL 
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3.5.5 Blotting 
 
To detect proteins in additional experiments, they were transferred to a 
membrane using a semi-dry blotting transfer method.45 Thick and thin Whatman 
papers and nitrocellulose paper were moistened with Transfer Buffer Mix (TBM) 
containing methanol. Gel was taken out of the glass frame using a thin Whatman 
paper. The materials on the Trans-Blot Cassette were arranged in the following 
order from bottom to top: thick Whatman paper, thin Whatman paper, 
nitrocellulose membrane, gel, thin Whatman paper, and thick Whatman paper.  
Applying 15V to the Trans-Blot Cassette, the proteins were blotted in 30 minutes 
from the gel to the nitrocellulose membrane. After a Ponceau S (Sigma- Aldrich, 
USA) staining, the protein lanes were visible and the nitrocellulose membrane 
was cut for further experiments and washed twice in ddH2O. For blocking, the 
nitrocellulose membrane was incubated for 60 minutes in 5% milk [containing 
2.5g fat-free milk powder (Non Dry Fat Milk, Sigma, USA), 25ml TBST, 25 ml 
ddH2O]. 
 
 
3.5.6 Immunostaining 
 
Proteins of interest were visualized for further analysis using immunostaining 
technique. In short, a primary antibody that binds to a specific protein epitope is 
detected by a secondary, horseradish-peroxidase-labelled antibody. A 
chemiluminescent substrate for horseradish peroxidase (HRP) is applied and the 
nitrocellulose membrane is exposed to an X-ray film. For washing nitrocellulose 
membrane, TBST [Tris-Buffered Saline containing 0.1% Tween 20 (Sigma-
Aldrich, USA)] was used.  
The primary antibody (ß-actin: monoclonal anti-beta-actin, clone ac-15, Sigma-
Aldrich, USA; CYP2E1: anti-CYP2E1, ab1252, Fisher Scientific, USA; SOD1: 
sheep anti-human superoxide dismutase, pc077, The Binding Site,UK;46 HSP27: 
HSP27 (C-20), sc-1048, Santa Cruz Biotechnologies, USA) was diluted 
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according to the manufacturer’s instructions in 5% milk, and nitrocellulose was 
incubated for 1h or overnight at 4°C. After thorough rinsing with TBST the 
corresponding secondary antibody, labelled with HRP, was diluted according to 
the manufacturer’s instructions in 10ml of 5% milk, and nitrocellulose was 
incubated for 30 to 60 minutes and afterwards was rinsed again for 20 minutes 
with TBST.  
For chemiluminescence, the membrane was incubated with 1.5ml SuperSignal 
solution (SuperSignal™ West Pico Chemiluminescent Substrate, Thermo Fisher 
Scientific, USA) for 5 minutes. Afterwards, the membrane was cleared of 
SuperSignal solution, wrapped in transparent polyethylene film and exposed for 5 
minutes to an X-ray film in an autoradiography cassette (Fisher Biotech 
Autoradiography Cassette, fbxc-810, Fisher Scientific, USA). Visibility and 
darkness of the protein lanes on the film (Blue X-Ray Film, 5 x 7, Phenix 
Research Products, USA) were appraised, and the exposure time was adjusted 
dependently. 
 
 
3.5.7 Densitometry 
 
The used densitometric method is based on the absorbance of light, which 
depends on the darkness of the X-ray film. Light was partly absorbed, and the 
decrease of incident light was measured electronically in a determined 
quantitative dynamic range for each target protein. The constitutively expressed 
housekeeping gene ß-actin was used as a loading control and served to 
normalize the loading of the protein of interest. Western blots with an overloading 
of ß-actin were excluded from the densitometrical analysis, and equal expression 
levels of ß-actin in different experimental conditions were assured.47 
 
3.6 Statistical Analysis 
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3.6.1 Image analysis 
 
All image analysis was performed with open-source NIH-ImageJ software 
(ImageJ 1.47f; National Institute of Health, USA). 
 
3.6.2 Statistical analysis  
 
The Mann–Whitney U rank-sum test was used for statistical analysis (Prism, 
GraphPad Software, Incorporated, La Jolla, CA, USA). Data are presented as 
mean ±SD, and a level of significance P ≤ 0.05 was selected. 
 
 
 
 
 
 
4 Results 
 
All primary hepatocytes were isolated as described in section 3.2 from C57BL/6 
background wild-type mice with a minimum age of 6 weeks. Primary hepatocytes 
were used instead of immortalized cell lines to exploit the most representative in 
vitro model for physiological processes. 
  
The viability was measured prior to experiments by Trypan Blue exclusion. The 
average viability of primary hepatocytes used in our experiments was 75.25 %.  
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4.1 Impact of IPA on primary hepatocyte cultures 
 
IPA was tested in different concentrations (exceeding physiologically measured 
concentrations of mammalian plasma) in primary hepatocyte cultures, and its 
effect on cell viability was evaluated by ALT release. 
 
IPA was used in concentrations of 0.1µM, 1µM, 10µM, and 100µM. The ALT 
enzyme activity levels in the supernatant were compared to a control group.19  
Every condition was plated in duplicate in 6-well plates with Media 199 containing 
0% FCS and incubated for 24h.   
There was no significant difference or trend between the control group and the 
IPA-treated conditions in the leakage of ALT (data not shown).  
Taken together, no hepatotoxic effect caused by the bacteria-derived compound 
IPA was visible. Primary hepatocytes showed neither any microscopically 
observable sign of additionally induced cytotoxic impact nor higher rates of 
detachment in vitro due to IPA.  
 
4.2 Cytotoxicity model 
 
To study hepatoprotective effects on primary hepatocytes, cell damage was 
induced with hepatotoxic CCl4. As described in section 3.4.2.3, cells were 
attached in a monolayer to the collagen-coated plate for 2h in a medium 
containing 10% FCS. Next, the media was changed to one containing either 10% 
or 0% FCS.30,48 
In accordance with relevant literature, CCl4 was applied in concentrations of 
c(CCl4)=5mM, 10mM, and 25mM.
33 To evaluate the dynamics of cell damage, 
different time points (6h and 24h after the start of CCl4 treatment) were set for 
measurement as shown in figure 1(A). Fatal cell damage causing ALT release, 
among other things, caused by the disintegration of cell membrane, was 
evaluated by the ALT enzyme activity in the supernatant (figure 1A).49 
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Fluorescence microscopy was performed after cells were stained with Hoechst 
and Propidium Iodide.50 Structural changes, especially signs of apoptosis and 
necrosis, were evaluated and found to be higher after 24h in randomly captured 
pictures of CCl4-treated conditions compared to the control (picture 5).  
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Figure 1(A): Cytotoxicity of different CCl4 concentrations with no serum 
proteins. 900.000 cells were plated per well (growth area 1.6 cm²) with n=3 wells 
per condition. No FCS was added to the culture media. ALT enzyme activity 
levels are shown after 6h and 24h. Mean values are shown with SD. 
 
 
As shown in the figure 1(A), the control with 0% FCS showed no substantial 
increase of ALT. Mean ALT enzyme activity in the control after a period of 6h 
was A(ALT,6h)= 17.90 U/l, and no change was evident after 24h 
(A(ALT,24h)=20.40 U/l). 
Promising results for establishing a cytotoxicity model were obtained with 0% 
FCS and c(CCl4)=10mM. No evident difference to the control was seen after a 
period of 6h with A(ALT,6h)= 20.60 U/l, but a four-fold increase of the 
transaminase activity level after 24h to A(ALT,24h)= 78.8 U/l could be detected.  
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Additional fluorescence microscopy data revealed a loss in cell plasma 
membrane integrity, particularly propidium iodide uptake, within 18.8% of primary 
hepatocytes after 24h.  
A closer look at the condition 0% FCS treated with 25mM CCl4 revealed the most 
promising cytotoxic impact after both 6h and 24h. The fluorescence microscopy 
showed that 32.01% of the cells were positive for propidium iodide after 24h. 
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Figure 1(B): Cytotoxicity of different CCl4 concentrations with 10% FCS. 
900.000 cells were plated per well (growth area 1.6 cm²) with n=3 wells per 
condition. 10% FCS was added to the culture media. ALT enzyme activity levels 
are shown after 6h and 24h. Mean values are shown with SD. 
 
 
Figure 1(B) shows primary hepatocytes treated for 24h with Media 199 
containing 10% FCS and varying concentrations of CCl4.
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In the control, ALT levels rose after 6h from A(ALT,6h)= 27.10 U/l to 
A(ALT,24h)=49.68 U/l after 24h. In the supernatant of the cell culture treated with 
c(CCl4)=10mM, the 6h ALT activity level was A(ALT,6h)=23.59 U/l, and it rose to 
A(ALT,24h)=61.24 U/l after 24h. With a concentration of c(CCl4)=25mM, the 6h 
value result of the ALT level was already A(ALT,6h)=45.50 U/l. 
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Distilled, any robust increase in ALT enzymes released into the supernatant was 
found after 24h with the media containing 10% FCS. 
 
4.3 Hepatoprotective effect of IPA 
4.3.1 First impression by dye uptake 
 
A first attempt to estimate the hepatoprotective potential of IPA was staining with 
Hoechst and propidium iodide. A promising hepatoprotective effect was a first 
rationale for further investigation. As exemplarily shown in picture 5, lower dye-
uptake after 24h was presented by hepatocytes, when an additional 1µM of IPA 
was applied to the medium. 
 
Picture 5: Light/Fluorescence microscopy of primary hepatocytes cultured for 
24h in 6-well plates under following condition: no treatment; 10mM CCl4; 10mM 
CCl4, and 1µM IPA.  
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4.3.2 CYP2E1 levels 
 
The cytochrome P450 system in hepatocytes is mainly responsible for the 
oxidative metabolism of xenobiotics as drugs or bacteria-derived toxic 
compounds. The CYP450 enzymes helped to estimate the maintenance of 
differentiation in the cultured primary hepatocytes.52 
CYP2E1 is the primary enzyme involved in the degradation of CCl4 to the 
reactive and toxic trichloromethyl radical (CCl3*), and it mediates the detrimental 
effect in CCl4 treatment.
32,53-55 
In n=3 experiments (see figure 2) primary hepatocytes in 6-well plates with 
900,000 cells per well for 24h in media containing 0% FCS following the SOP 
were cultured. Each condition was cultured in triplicate, whole protein extracts 
were pooled, and immunoquantification was performed by SDS-PAGE with the 
antibody described in section 3.5.  
CYP2E1 protein expression level was normalized with ß-actin as a loading 
control.56 No significant difference in the expression of CYP2E1 occurred. 
Nevertheless, an apparent trend in protein level could be characterized as a 4-
fold decrease in conditions with CCl4 alone. With the presence of 0.1 µM IPA, 
only a 2-fold decrease of CYP2E1 after treatment with CCl4 for 24h (0.58 fold 
control) was quantified. Subsequently, with 10 mM of CCl4 and an IPA 
concentration of 1 µM, even a 1.76-fold increase of CYP2E1 protein expression 
level after 24h compared to the control condition was observed. A 1.18-fold 
increase with 0.1 µM IPA alone and a questionable dose-dependent 1.44-fold 
increase with 1 µM IPA alone was found. 
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Figure 2: Equal bioactivation of CCl4 with and without IPA.  
In n=3 experiments primary hepatocytes were cultured for 24h under each 
condition in triplicate. CCl4 concentration was 10mM and IPA concentrations 
were 0µM (nothing), 0.1µM, and 1µM. CYP2E1 protein levels were identified by 
normalizing to ß-actin and are shown in comparison to the control condition. 
Mean values are shown with SD. 
 
 
4.3.3 Cell damage marker levels in vitro  
 
 
Figures 3–5 summarize and quantify the cell damage caused by various 
mechanisms of CCl4-mediated cytotoxicity in primary hepatocyte cultures after 
24h of treatment with and without IPA treatment. 
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4.3.3.1 ALT enzyme leakage 
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Figure 3(A) Impact of IPA on ALT enzyme leakage.  
9 x 105 hepatocytes were cultured as described in section 3.4 and treated with 
IPA-concentrations of 0µMm (control), 0.1µM, and 1µM and are compared to 
treatment with CCl4. In n=8 independent isolations, each condition was 
performed in triplicate. Absolute enzyme-activity of ALT in the medium after 24h 
was measured. Mean values are shown with SD. 
 
 
 
In figure 3(A), ALT levels in the culture media are shown. Under control 
conditions, the enzyme activity after 24h in the culture media was significantly 
lower (P= 0.0002) than after CCl4 treatment. Furthermore, hepatocytes treated 
with 0.1µM (P= 0.0002) and 1µM (P=0.0019) IPA showed significantly lower 
enzyme activity than the CCl4-treated cells. 
Treating only with IPA did not show significant differences compared to the 
control group. 
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Figure 3(B): Protective effect of IPA on hepatocytes (dose dependent) after 
CCl4 treatment.  
9 x 105 hepatocytes were cultured as described in section 3.4 and treated with 
CCl4 and IPA-concentrations of 0µM (control), 0.1µM, and 1µM. In n=8 
independent isolations each condition was performed in triplicate. Absolute 
enzyme activity of ALT in the medium after 24h was measured. Mean values are 
shown with SD. 
 
 
In Figure 3(B), ALT levels in the culture media after 24h of treatment with CCl4 
were measured. Interestingly, the data show a dose-dependent decrease of ALT 
enzyme leakage with rising IPA levels. Mean ALT levels in the control condition 
declined with treatment of 0.1µM IPA and further decreased significantly 
(P=0.0047) with 1µM IPA compared to the control condition, which was solely 
treated with CCl4. 
Treatment with CCl4 and different 
concentrations of IPA 
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4.3.3.2 LDH enzyme leakage  
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Figure 4(A): Impact of IPA on LDH enzyme leakage. 
Using the method described in section 3.4, 9 x 105 hepatocytes were cultured 
and treated with IPA concentrations of 0µM (control), 0.1µM, and 1µM and are 
compared to treatment with CCl4. In n=6 independent isolations, each condition 
was performed in triplicate. Absolute enzyme-activity of LDH in the medium after 
24h was measured. Mean values are shown with SD. 
 
 
In Figure 4(A), LDH levels in the culture media were measured. After 24h 
enzyme activity found in the control sample was significantly lower (P= 0.0022) 
than after CCl4 treatment.  
Moreover, conditions treated with 0.1µM (P= 0.0022) and 1µM (P= 0.0043) of 
IPA caused significantly lower enzyme activity than the CCl4-treated condition in 
the supernatant. 
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Addition of IPA alone did not lead to significant differences in LDH enzyme 
activity levels compared to the control group. 
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Figure 4(B): Protective effect of IPA on hepatocytes (dose dependent) after 
CCl4 treatment. 
As described in section 3.4, 9 x 105 hepatocytes were cultured and treated with 
CCl4 and IPA-concentrations of 0µM (control), 0.1µM, and 1µM. In n=6 
independent isolations each condition was performed in triplicate. Absolute 
enzyme activity of LDH in the medium was measured after 24h. Mean values are 
shown with SD. 
 
In Figure 4(B), treatment of hepatocytes with carbon tetrachloride 
(c(CCl4)=10mmol/l) for 24h prior to the observations of enzyme levels was 
performed for every condition.  
As the IPA dose was increased to 1 µM, the leakage of enzymes could be 
reduced to a significant difference compared with the control. 
Treatment with CCl4 and different 
concentrations of IPA 
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4.3.4 Oxidative stress in primary hepatocytes in vitro 
 
Oxidative stress was measured as described in section 3.4.4 from whole cell 
extracts using the OxiSelect TBARS assay. TBARS quantifies ROS indirectly and 
is shown in the figures in arbitrary units.57 
 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5(A): Oxidative stress in hepatocytes is reduced by IPA.  
As described in section 3.4, 9 x 105 hepatocytes were cultured and treated with 
IPA-concentrations of 0µM (control), 0.1µM, and 1µM and are compared to 
treatment with CCl4. In n=7 independent isolations each condition was performed 
in triplicate. Mean values are shown with SD. 
 
 
As shown in Figure 5(A), the TBARS were significantly induced by treatment of 
primary hepatocytes with 10mM of toxic CCl4 in relation to the baseline of the 
control or to IPA treatment. IPA treatment did not alter the TBARS concentration 
after 24h compared to the control significantly. 
fo
ld
 
 
 
TBARS 
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Figure 5(B): Oxidative stress is reduced in hepatocytes by IPA. 
As described in section 3.4, 9 x 105 hepatocytes were cultured and treated with 
CCl4 and IPA-concentrations of 0µM (control), 0.1µM, and 1µM. In n=4 
independent isolations each condition was performed in triplicate. Mean values 
are shown with SD. 
 
 
To validate IPA’s potential of reducing the toxic impact of CCl4, TBARS were 
measured in hepatocyte cultures simultaneously treated with 10mM CCl4 and 
treated with IPA. TBARS decreased with IPA treatment dose dependently as 
shown in Figure 5(B). A significant decrease of TBARS could be assessed with 
1µM IPA treatment compared to treatment with CCl4 alone. 
 
 
 
TBARS after treatment with 10 mM CCl4 and 
different concentrations of IPA 
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4.4 Role of IPA in hepatic metabolism in additon to antioxidant 
properties 
 
 
The rationale for further screening of protein induction by IPA was the protective 
properties of IPA in mammalian metabolism. As the first attempt of Venkatesh et 
al. suggests, IPA was found to serve as a PXR ligand and likely influences TNF-α 
and mRNA levels, and protein expression in enterocytes in vivo.  
 
Sakurai et al. investigated the pathways of compensatory proliferation and liver 
tumor promotion. They paid attention to the effect of ROS accumulation in 
hepatocarcinogenesis and found, downstream of p38α, that HSP27 has an 
antioxidant effect associated with its ability to restore reduced Glutathione (GSH) 
and compensate the toxic effect of oxidized proteins leading to less ROS but 
JNK-mediated compensatory proliferation. Another route, downstream of IKKß 
and NF-κB, superoxide dismutase (SOD) was defined as a critical antioxidant. 58 
 
 
4.4.1 SOD1 
 
As a housekeeping antioxidant protein, SOD1 reduces superoxide in hydrogen 
peroxide, which is further metabolised by other proteins.59-62 
 
 
 47 
 SOD1
condition for 24h
fo
ld
no
th
in
g
C
C
l4
C
C
l4
 +
 0
.1
 IP
A
C
C
l4
 +
 1
 IP
A
0.
1 
IP
A
1 
IP
A
0
5
10
15
*
*
 
 
Figure 6: relative SOD1 protein levels in hepatocytes. 
Protein levels were assessed using a Western Blot analysis. As described in 
section 3.4, 9 x 105 hepatocytes were cultured and treated with CCl4 (c=10mM) 
and IPA-concentrations of 0µM (nothing), 0.1µM, and 1µM for 24h. In n=4 
independent isolations each condition was performed in triplicate. Mean values 
are shown with SD. 
 
 
SOD1 protein concentration normalized to the housekeeping gene ß-actin was 
assessed using a Western Blot analysis and densitometry. Results are 
expressed in relation to a control untreated hepatocyte culture.  
SOD1 was found to be upregulated to a significant extent. 
 After exposure to the impact of free radicals, stemming from the bioactivation of 
10mM CCl4 in the primary hepatocytes culture, significant SOD1 upregulation 
could be observed when 1µM IPA was applied simultaneously to the cell culture. 
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SOD1 was significantly induced under solely 0.1µM IPA treatment compared to 
the control (Figure 6). 
 
 
4.4.2 HSP27 
 
Chaperones such as HSP 27 provide an important antiapoptotic and antioxidant 
function.63 The metabolic regulation of chaperones is not completely understood 
at this time.64 
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Figure 7: relative HSP27 protein levels in hepatocytes. 
Protein levels were assessed with a Western Blot analysis. As described in 
section 3.4, 9 x 105 hepatocytes were cultured and treated with CCl4 (c=10mM) 
and IPA-concentrations of 0µM (nothing), 0.1µM, and 1µM for 24h. In n=4 
independent isolations each condition was performed in triplicate. Mean values 
are shown with SD. 
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In primary hepatocytes, the baseline HSP27 protein concentration of the control 
was compared to treatment with 10 mM CCl4 and is found to be significantly 
reduced to very low levels. Evidently, HSP27 was restored with IPA treatment. 
 
When a dose of 1µM IPA is applied during treatment with CCl4, the total HSP27 
protein expression in vitro is significantly higher than under CCl4 alone. 
Interestingly, with IPA treatment alone, HSP27 was induced more than  2-fold. 
 
Considering these results, the potential of using IPA to induce HSP27 was 
hypothesized. In a subsequent experiment, IPA was applied in a linearly 
increasing concentration with a range of up to100µM. 
 
 
c(IPA) [µM]       0      0.1      1      10    100   100 
 
            ß-Actin           
 
 
             HSP27          
 
 
Figure 8: Protein levels of HSP27 after IPA stimulation in hepatocytes. 
9 x 105 cells per well were stimulated for 24h with IPA in the concentrations of 
0µM, 0.1µM, 1µM,10µM, and 100µM. ß-actin was used as loading control. N=4 in 
separate experiments.  
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As shown in figure 8, all lanes were equally loaded assuring representative 
results for HSP27 protein expression. No change in HSP27 protein expression 
could be observed under any concentration of IPA treatment alone.  
 
 
5 Discussion 
 
The present study was designed to determine the effect of IPA on primary 
hepatocytes. It found a dose-dependent hepatoprotective effect of IPA on 
primary hepatocytes in vitro. In the study design, the regenerative capacity of 
hepatocytes was challenged with hepatotoxic CCl4, which is commonly used in 
liver research.  
The antioxidant activity of IPA, particularly its hydroxyl radical scavenging 
potential, has been investigated by Chyan et al. and compared to other potent 
radical scavengers, such as vitamins C and E or glutathione, no pro-oxidant 
intermediates were found to be built with IPA.19  
Accordingly, IPA was used up to a maximum concentration of 100µM and 
showed no harmful impact in cultures of primary hepatocyte. Quantification of the 
pH shift was found to be unnecessary due to the low concentrations of IPA both 
in vivo and in vitro. However, Karbownik et al. cannot exclude a direct pro-
oxidative effect of IPA, which was suggested because of alterations in membrane 
fluidity after IPA treatment. 
An objective of this project was to identify hepatoprotective effects of IPA. 
Therefore cultured primary hepatocytes were used because they represent a 
system considered biochemically equivalent to an intact liver for haloalkane 
effects and are, as suggested by Soars et al., more useful than hepatic 
microsomes in terms of accomplishing a better in vitro – in vivo 
extrapolation.32,65,66  
In a systematic approach, the conscientious establishment of standard operating 
procedures and commitment to them (e.g., for hepatocyte isolation, growing 
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cultures, and modeling cytotoxicity) was deemed crucial to obtaining reproducible 
results. 
Preparatory steps were strictly standardized. As the literature suggested for 
hepatocyte isolation, the viability of primary hepatocytes depends on factors such 
as perfusate flow and complete solubility of the reagents. Cannulation of the VCI 
and retrograde perfusion was favored because of the reproducibility of the same 
viability and easier cannulation compared to perfusion via the portal vein.30 
 
Dedifferentiation of the hepatocytes in vitro was anticipated and so as a 
precautionary measure, the experimental design was adapted to ensure validity 
of the model.67 Subsequently, a short period of culturing and serum starvation of 
the hepatocytes was favored (hepatocytes were harvested 26h after seeding).68 
Other factors such as the extracellular environment of cultured hepatocytes and 
media supplements were considered after consulting the latest literature. 
Concerning the extracellular matrix and its configuration, Tuschl et al. conclude 
from their protein profiling studies on cultured primary murine hepatocytes that 
collagen-monolayer-culture conditions in serum-free media maintains liver-like 
features for the required time period and was therefore validated as appropriate 
to the study design. Nevertheless, 3D spherical organoids are used because they 
replicate the in vivo functions of the liver better than the hepatocyte monolayer 
culture does.69,70  
The CCl4 cytotoxicity model chosen in this study is well established as an 
excellent tool in the liver research community.32 Hepatic injury induced through 
CCl4 has been used extensively in experimental models to understand and 
evaluate the therapeutic potential of dietary antioxidants and drugs.71  
In his review, Weber et al. analyzed CCl4 as a toxicological model and describes 
CCl4 as an important model substance for studying hepatotoxic effects such as 
fatty degeneration, hepatocellular death, carcinogenicity, and fibrosis. He outlines 
that CCl4 toxicity depends on dose, exposure time, the presence of potentiating 
agents, and on the age of the affected organism. In a finely tuned balance, the 
CCl4 model reveals the opportunity in vivo for full regeneration from liver damage. 
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One mayor drawback of this model, from a practical point of view, is the volatility 
of CCl4.
32 
Clawson et al. conclude that hypomethylation of ribosomal RNA takes place in 
CCl4-mediated cellular damage and parallel the CCl4-induced inhibition of protein 
synthesis, which could affect the protein expression level analysis in this 
study.72,73 
Furthermore, FCS in the culture medium was found to interfere with the CCl4-
induced toxicity over a time period of 24h. Th literature suggests a significant 
amount of SOD activity in the FCS, which is considered to be a possible 
explanation for the observed results.74 
Central to CCl4 toxicity are the cytochromes P450 (CYPs), and subsequently 
CYP2E1 knockout mice were resistant to hepatotoxicity induced by CCl4.
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CYP2E1 activates CCl4 and the trichloromethyl CCl3* is formed. 
Because all hepatotoxic effects originate in the bioactivation of CYP2E1, its 
concentration was monitored precisely.  
Considering the results presented in section 4.3.2, no significant changes in 
CYP2E1 levels compared to the control condition were found. Equal bioactivation 
of CCl4 and, subsequently, equal hepatotoxic effect in all experiments can be 
assumed. However, in CCl4-treated cultures, the mean CYP2E1 protein level is 
likely to be lower than the control according to the literature. In line with this 
consideration, a 4-fold decrease of CYP2E1 could be valued within the CCl4 
condition.75 
The immunodetectable protein contents of CYP2E1 are known to be 
downregulated time-dependently after CCl4 treatment. This is probably due to 
specific destruction caused by its own metabolized substrate.76 CYP2E1 was 
also reported to have a very short half-life of 7-8h, suggesting a susceptibility to 
proteolysis. This would explain the observed trend reported in section 4.3.2.77 
One of the most important findings of this study, enzyme leakage of the 
intracellular enzymes LDH and ALT was significantly reduced by IPA in a dose-
dependent manner in primary hepatocytes. All measured results were in the 
linearity-range of the test setup (compare section 3.4.3.1). It is therefore evident 
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that a correlation between IPA concentration and hepatoprotection in vitro exists. 
 
These results are in agreement with those obtained by prior studies.  
Chyan et al. assume from three independent duplicate experiments with SK-N-
SH human neuroblastoma cells exposed to the superoxide dismutase inhibitor 
diethyldithiocarbamate (DDTC) or to oxidative stress mediated by H2O2, a 
neuroprotective effect, using Trypan Blue exclusion. In their analysis, Chyan et 
al. quantify a protective effect of IPA in neurons, which they show to be at least 
twice as potent as the antioxidant melatonin and exceeds the melatonin serum 
concentration in vivo. By applying an IPA concentration up to 100µM, the 
maximum protective effect, which more precisely suggests a saturation value, 
was reached with 10µM.  
Lefler et al. conducted experiments in vivo of IPA pretreatment (10mg/kg) in mice 
prior to an ischemic event, modeling liver transplantation. Their focus was on the 
prevention of excessive tissue damage and so liver enzymes were used as 
markers for liver dysfunction. A significant decrease of both ALT and AST were 
found in a 2h reperfusion period.78  
The aforementioned mechanisms of CCl4 toxicity provoke cell damage, reflected 
by structural changes and membrane disintegration. Concomitantly to enzyme 
release, dye uptake of Propidium Iodide increased after CCl4 treatment and 
necrotic structural changes were seen microscopically, which facilitated the 
estimation of the extent of cell damage.  
The detailed mechanism of CCl4 hepatotoxic effects on a molecular level is 
mediated via CCl3*
79 and its derivatives binding to cellular molecules as proteins, 
nucleic acids, and lipids.  
The highly reactive radicals are known to impair essential metabolic processes 
such as lipid metabolism. They also affect DNA as they form adducts between 
the nucleic acids, and in the presence of oxygen, they launch the chain reaction 
of lipid peroxidation.79  
The trichloromethyl peroxy radical (CCl3OO*) is mainly responsible for lipid 
peroxidation80, which affects polyunsaturated fatty acids (PUFA), particularly 
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those related to phospholipids. As a result of lipid peroxidation, fluidity and 
permeability of the plasma membrane, of the mitochondrial membranes, and of 
the endoplasmic reticulum`s membrane are changed pathologically. 
Subsequently, the calcium homeostasis and sequestration among other things 
are affected and contribute to total cellular damage.81  
The most important mechanism of CCl4-induced toxicity, haloalkylation or lipid 
peroxidation,  contributes the most to radically induced cell damage and cell 
necrosis in hepatocytes and is discussed herein. 
This study focused on the TBARS assay to measure the aldehydic secondary 
products of lipid peroxidation as Malondialdehyde (MDA) and 4-hydroxynonenal 
(4-HNE). 
The current study found a significant induction of lipid peroxidation due to CCl4 
and a dose-dependent reduction of TBARS after IPA treatment. Again, dose-
dependency strongly suggests a hepatoprotective effect of IPA. 
These results are further supported by the findings of Karbownik et al., who 
experimentally induced oxidative changes in rat hepatic microsomal membranes 
with FeCl3 (0.2 mM), ADP (1.7 mM) and NADPH (0.2 mM) and found a decrease 
of lipid peroxidation with a ten times higher IPA concentration as compared to the 
results in this study. This might be due to the forceful lipid peroxidation potential 
of ADP-Fe3+, which is  five to six times that of CCl4.
82  
 
Poeggeler et al. found IPA directly scavenging hydroxyl radicals with a rate 
constant of 7.8 x 1010 mol l-1 s-1. They also found that IPA attenuated the 
hydrogen peroxide–induced, hydroxyl radical–mediated MDA formation in rat 
striatal homogenates in a concentration-dependent manner with 50% of inhibition 
mediated by 180 µM of IPA. Interestingly, IPA´s hydroxyl radical-scavenging 
efficacy was potentiated with co-treatment of the endogenous antioxidant 
glutathione, suggesting that there might be a symbiotic relationship between the 
bacteria-derived products and the cellular homeostasis. 
SOD1 is a copper and zinc-containing homodimer and is found in cytoplasm, 
nucleus, microsomes, and in the intermembrane space of mitochondria.83,84 
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Miao et al. found as transcriptional factors of the SOD enzyme family NF-κB, 
Sp1, AP-1, AP-2, and CCAAT-enhancer-binding protein (C/EBP). 
Venkatesh et al. conjecture that a cellular target of IPA exists but is not evident in 
the recent literature. To ascertain if IPA could potentially regulate intestinal 
barrier function through the nuclear pregnane X receptor (PXR), in vitro and in 
vivo studies of the effect of IPA on inflammation and gut barrier function were 
conducted, and the regulatory function of IPA in enteric inflammation through the 
PXR could be demonstrated. 
IPA was identified as a ligand for PXR in vivo and further downregulated TNF-α 
while it upregulated junctional protein-coding mRNAs in enterocytes.15 
In this study, SOD1 protein concentration was found to be upregulated 
significantly when hepatocytes where stressed with CCl4 in co-incubation with 
1µM IPA. A tendency of SOD1 protein induction under solely IPA treatment was 
even significant for 0.1µM IPA compared to the baseline of the control. A 
possible explanation for these results might be that an intracellular signal 
transduction in hepatocytes with a subsequent enzyme induction, as was 
recently found in enterocytes, exists. As the hepatocytes culture was serum 
starved during the IPA incubation, low basal activities of hepatocytes but high 
responsiveness to specific stimuli was assured according to Klingmüller et al., 
and cells were generally susceptible to small changes in ligand concentration of 
intracellular signal transduction. Therefore an upregulation of SOD1 could be the 
result of an unknown IPA ligand function. These findings could help expand the 
present antioxidant role of IPA. To develop a full picture of IPA`s role in 
hepatocytes, additional studies to investigate the dynamics of protein induction 
with more powerful methods than solely protein expression levels are needed. 
ROS are released in the liver as physiological inflammatory response by resident 
macrophages (Kupffer cells) or by activated and recruited monocytes or 
neutrophils.85,86 ROS-induced intracellular oxidant stress in hepatocytes involves 
the promotion of mitochondrial dysfunction and contributes primarily to oncotic 
necrosis and less apoptosis.86 While effects that influence the cell directly were 
depicted within this type of in vitro model, the significant role of non-parenchymal 
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cells and the inflammatory response of the liver tissue to CCl4 treatment of 
hepatocytes, as mediated by proinflammatory cytokines such as TNF-α and 
released ROS, were beyond the scope of this study.35,87  
HSP27 is a protein that exhibits chaperone-like activity. It is induced by diverse 
mechanisms and is currently understood to play an ambiguous role with 
cytoprotective (chaperone-like activity, anti-apoptotic) as well as partly 
oncogenic64 properties. 
In this study, HSP27 was significantly reduced under CCl4 treatment. By contrast, 
HSP70 protein increased by 20% after 24h of CCl4 treatment in vivo (Knockaert 
et al.88). 
An important finding was the significant upregulation of HSP27 after co-
incubation with IPA and CCl4 compared to both the control and to the CCl4 
treatment. 
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